All In Biotech

Drug Trial Radar · NCT02598596

Tolerization Reduces Intolerance to Pegloticase and Prolongs the Urate Lowering Effect

Last checked: Nov 20, 2026Latest source record: Oct 11, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

132

Actual

Start

Dec 2015

Primary completion

Apr 13, 2020

Study completion Apr 27, 2020

Sponsor

Lead sponsor
Ampel BioSolutions, LLCIndustry
Sponsor type
Industry
Collaborators
IND 2 Results LLC
First posted
Nov 6, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Non randomized
Model
Single group
Masking
None
Primary purpose
Other
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the effect of a high zone tolerizing regimen of pegloticase on clinical outcome, as defined by an serum uric acid level \<6 mg/dL, in patients with chronic, refractory gout.

Conditions

  • Gout

Interventions

  • PegloticaseBiological

    Pegloticase, IV

  • AzathioprineDrug

    Azathioprine (1.25 mg/kg, followed by 2.5 mg/kg) oral, daily

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Normalization of serum uric acid (SUA) in subjects receiving a tolerizing regimen of pegloticaseTime frame: Week 17
  2. Normalization of serum uric acid (SUA) in subjects receiving pegloticase and azathioprine (AZA) immunosuppressive therapyTime frame: Week 25

Locations

11 sites in 1 country. Site status is shown where the registry gives one.

  • University of Alabama at Birminingham

    Birmingham, Alabama

  • Rheumatology Associates of North Alabama

    Huntsville, Alabama

  • The Center for Rheumatology and Bone Research

    Wheaton, Maryland

  • Clinical Pharmacology Study Group

    Worcester, Massachusetts

  • Henry Ford Health System

    Detroit, Michigan

  • Saint Paul Rheumatology

    Eagan, Minnesota

  • Buffalo Rheumatology and Medicine

    Orchard Park, New York

  • Montefiore Medical Center

    The Bronx, New York

  • Cleveland Clinic

    Cleveland, Ohio

  • Altoona Center for Clinical Research

    Duncansville, Pennsylvania

  • ACME Research, LLC

    Orangeburg, South Carolina

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.